Hsbc Holdings PLC Purchases 41,825 Shares of Xylem Inc. $XYL

Hsbc Holdings PLC increased its holdings in Xylem Inc. (NYSE:XYL) by 2.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,000,691 shares of the industrial products company’s stock after buying an additional 41,825 shares during the period. Hsbc Holdings PLC’s holdings in Xylem were worth $272,622,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. J. Stern & Co. LLP raised its holdings in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Xylem by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock worth $4,092,855,000 after purchasing an additional 152,507 shares in the last quarter. State Street Corp increased its position in shares of Xylem by 2.6% in the fourth quarter. State Street Corp now owns 11,233,427 shares of the industrial products company’s stock worth $1,529,768,000 after purchasing an additional 280,221 shares during the last quarter. Geode Capital Management LLC raised its stake in Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 6,357,278 shares of the industrial products company’s stock valued at $862,364,000 after purchasing an additional 151,754 shares in the last quarter. Finally, Swedbank AB lifted its position in Xylem by 6.0% during the fourth quarter. Swedbank AB now owns 5,507,966 shares of the industrial products company’s stock valued at $750,075,000 after purchasing an additional 310,213 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on XYL shares. Oppenheimer lowered their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Citigroup lowered their price target on Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Jefferies Financial Group reiterated a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a report on Tuesday, March 31st. Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Finally, UBS Group raised their price objective on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and an average target price of $152.77.

Insider Activity at Xylem

In related news, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, with a total value of $141,098.10. Following the purchase, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. The trade was a 54.22% decrease in their position. The SEC filing for this sale provides additional information. 0.32% of the stock is owned by company insiders.

Xylem Price Performance

Shares of NYSE:XYL opened at $111.44 on Friday. The stock has a market cap of $26.49 billion, a PE ratio of 27.72, a PEG ratio of 1.59 and a beta of 1.04. The company’s fifty day moving average is $114.53 and its 200 day moving average is $126.30. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. During the same period in the prior year, the business posted $1.03 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date is Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Xylem announced that its Board of Directors has initiated a share repurchase program on Wednesday, February 25th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.